Cite
A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor.
MLA
Yuan Mao, et al. “A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor.” International Journal of Molecular Sciences, vol. 13, no. 2, Feb. 2012, pp. 2208–18. EBSCOhost, https://doi.org/10.3390/ijms13022208.
APA
Yuan Mao, Da-Wei Zhang, Juan Wen, Qing Cao, Ren-Jie Chen, Jin Zhu, & Zhen-Qing Feng. (2012). A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor. International Journal of Molecular Sciences, 13(2), 2208–2218. https://doi.org/10.3390/ijms13022208
Chicago
Yuan Mao, Da-Wei Zhang, Juan Wen, Qing Cao, Ren-Jie Chen, Jin Zhu, and Zhen-Qing Feng. 2012. “A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor.” International Journal of Molecular Sciences 13 (2): 2208–18. doi:10.3390/ijms13022208.